MYD.HM MYRIAD GENETICS
- Market cap
- -
- P/E
- -
- P/B
- 1.84x
- ROE
- -99.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is MYD.HM undervalued?
Graham numberThe Graham number of MYRIAD GENETICS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MYRIAD GENETICS fundamental analysis
No fundamental analysis for MYRIAD GENETICS yet.
MYRIAD GENETICS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
MYRIAD GENETICS financial statements
MYRIAD GENETICS annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 754M | 771M | 773M | 851M | 639M | 691M | 678M | 753M | 838M | 825M |
| Gross Profit | 597M | 600M | 595M | 650M | 453M | 493M | 476M | 517M | 585M | 577M |
| Operating Income | 167M | 49.4M | 57.5M | 8.70M | -135M | -127M | -124M | -145M | -88.0M | -67.8M |
| EBITDA | - | 97.2M | 175M | 85.0M | -141M | 12.3M | -84.7M | -197M | -59.5M | -331M |
| Net Income | 125M | 21.8M | 131M | 4.60M | -200M | -27.2M | -112M | -263M | -127M | -366M |
| EPS | - | 0.32 | 1.86 | 0.06 | -2.67 | -0.34 | -1.38 | -2.93 | -1.39 | -3.91 |
| Balance Sheet | ||||||||||
| Total Assets | 881M | 1.22B | 1.17B | 1.56B | 1.40B | 1.32B | 1.20B | 1.15B | 1.03B | 707M |
| Total Liabilities | 132M | 447M | 209M | 474M | 486M | 353M | 313M | 363M | 327M | 339M |
| Shareholders' Equity | 748M | 778M | 965M | 1.09B | 918M | 968M | 886M | 783M | 701M | 368M |
| Cash & Short-term Investments | 68.5M | 102M | 111M | 93.2M | 164M | 257M | 56.9M | 132M | 102M | 150M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 166M | 106M | 116M | 83.7M | 60.7M | 18.6M | -106M | -111M | -8.70M | 1.80M |
| Capital Expenditure | 5.00M | 6.10M | 8.40M | 8.60M | 10.2M | 18.0M | 45.3M | 73.3M | 29.7M | 27.4M |
| Free Cash Flow | - | 100M | 108M | 75.1M | 50.5M | 600K | -152M | -184M | -38.4M | -25.6M |
| Ratios | ||||||||||
| ROE | 16.7% | 2.8% | 13.6% | 0.4% | -21.7% | -2.8% | -12.6% | -33.6% | -18.2% | -99.4% |
| ROA | 14.2% | 1.8% | 11.2% | 0.3% | -14.2% | -2.1% | -9.3% | -23.0% | -12.4% | -51.8% |
| Net Profit Margin | 16.6% | 2.8% | 17.0% | 0.5% | -31.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MYRIAD GENETICS dividends
MYRIAD GENETICS has not paid dividends in the last 10 fiscal years.
Who owns MYRIAD GENETICS
Ownership data of MYRIAD GENETICS is not available yet.
MYRIAD GENETICS company profile
- Company name
- MYRIAD GENETICS
- Ticker
- MYD.HM
- Exchange
- Hamburg Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- June
- Address
- Website
- -
About MYRIAD GENETICS
There is no Profile data available for MYD.HM.